Gleevec and Diazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Diazepam (diazepam). Common drug interactions include blood cholesterol increased among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Diazepam. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.



On Jul, 16, 2026

65 people who take Gleevec and Diazepam together, and have interactions are studied.

Gleevec and Diazepam drug interactions.

What are the common drug interactions of Gleevec and Diazepam, by gender? *:

female:

  1. Blood cholesterol increased
  2. Blood glucose increased
  3. Blood pressure increased
  4. Cardiac failure congestive
  5. Chest pain
  6. Confusional state
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Dizziness
  9. Dyslipidaemia (abnormal amount of lipids)
  10. Embolic stroke (stroke due to obstruction due to an embolus)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Constipation
  3. Depression
  4. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  5. Erectile dysfunction
  6. Neuropathy peripheral (surface nerve damage)
  7. Overdose
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Restlessness (not able to rest)
  10. Skin fissures (a crack in the skin)

What are the common drug interactions of Gleevec and Diazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Burning sensation
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Overdose
  4. Restless legs syndrome (a powerful urge to move your legs)
  5. Restlessness (not able to rest)

30-39:

  1. Blood bilirubin increased
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

40-49:

  1. Death
  2. Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
  3. General physical health deterioration (weak health status)
  4. Haemoglobin decreased
  5. Infection
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Platelet count decreased
  9. Pyrexia (fever)
  10. Bone marrow tumour cell infiltration

50-59:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Chronic kidney disease
  3. Nausea (feeling of having an urge to vomit)
  4. Platelet count decreased
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Vomiting
  7. Weight decreased

60+:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Depression
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Melaena (the passage of black, tarry stools)
  7. Migraine (headache)
  8. Post procedural complication
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Speech disorder

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 25 people, 38.46%
  2. Pain: 8 people, 12.31%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.23%
  4. Migraine (headache): 5 people, 7.69%
  5. Gastrointestinal Stromal Tumor: 5 people, 7.69%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Diazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gleevec and Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on imatinib mesylate and diazepam (the active ingredients of Gleevec and Diazepam, respectively), and Gleevec and Diazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: